Prudential Financial Inc Inovio Pharmaceuticals, Inc. Transaction History

Prudential Financial Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.41 - $2.5 $239 - $425	170 Added 0.96%	17,810 $0
Q3 2022 Nov 04, 2022	BUY	$1.66 - $2.79 $2,822 - $4,743	1,700 Added 10.66%	17,640 $30,000
Q4 2021 Feb 14, 2022	SELL	$4.99 - $7.46 $4,940 - $7,385	-990 Reduced 5.85%	15,940 $80,000
Q3 2021 Nov 15, 2021	BUY	$7.16 - $9.69 $4,725 - $6,395	660 Added 4.06%	16,930 $121,000
Q2 2021 Aug 16, 2021	BUY	$6.23 - $10.03 $13,207 - $21,263	2,120 Added 14.98%	16,270 $151,000
Q1 2021 May 12, 2021	BUY	$8.81 - $16.96 $14,007 - $26,966	1,590 Added 12.66%	14,150 $131,000
Q4 2020 Feb 16, 2021	BUY	$8.5 - $12.85 $2,125 - $3,212	250 Added 2.03%	12,560 $111,000
Q3 2020 Nov 16, 2020	BUY	$9.57 - $27.05 $5,837 - $16,500	610 Added 5.21%	12,310 $143,000
Q2 2020 Aug 12, 2020	BUY	$7.14 - $31.69 $83,538 - $370,773	11,700 New	11,700 $315,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $496M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.